Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $157B |
| FY2017, ended Dec 31, 2017 | $141B |
| FY2018, ended Dec 31, 2018 | $101B |
| FY2019, ended Dec 31, 2019 | $119B |
| FY2020, ended Dec 31, 2020 | $112B |
| FY2021, ended Dec 31, 2021 | $120B |
| FY2022, ended Dec 31, 2022 | $128B |
| FY2023, ended Dec 31, 2023 | $150B |
| FY2024, ended Dec 31, 2024 | $204B |
| FY2025, ended Dec 31, 2025 | $278B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $208B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $79.9B |
| FY2017, ended Dec 31, 2017 | $79.1B |
| FY2018, ended Dec 31, 2018 | $79.6B |
| FY2019, ended Dec 31, 2019 | $57.7B |
| FY2020, ended Dec 31, 2020 | $55.2B |
| FY2021, ended Dec 31, 2021 | $57.4B |
| FY2022, ended Dec 31, 2022 | $60.5B |
| FY2023, ended Dec 31, 2023 | $61.9B |
| FY2024, ended Dec 31, 2024 | $62.8B |
| FY2025, ended Dec 31, 2025 | $67.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $69.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $11.9B | $13.5B |
| FY2017, ended Dec 31, 2017 | $5.75B | $13.5B |
| FY2018, ended Dec 31, 2018 | $8.73B | $11.9B |
| FY2019, ended Dec 31, 2019 | $9.43B | $12.5B |
| FY2020, ended Dec 31, 2020 | $5.59B | $15.6B |
| FY2021, ended Dec 31, 2021 | $5.74B | $10.7B |
| FY2022, ended Dec 31, 2022 | $1.64B | $9.09B |
| FY2023, ended Dec 31, 2023 | $7.50B | $12.7B |
| FY2024, ended Dec 31, 2024 | $6.02B | $12.4B |
| FY2025, ended Dec 31, 2025 | $10.6B | $12.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.2B | $14.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.83B |
| FY2017, ended Dec 31, 2017 | $12.0B |
| FY2018, ended Dec 31, 2018 | $11.4B |
| FY2019, ended Dec 31, 2019 | $8.17B |
| FY2020, ended Dec 31, 2020 | $13.2B |
| FY2021, ended Dec 31, 2021 | $6.65B |
| FY2022, ended Dec 31, 2022 | $7.89B |
| FY2023, ended Dec 31, 2023 | $13.1B |
| FY2024, ended Dec 31, 2024 | $13.9B |
| FY2025, ended Dec 31, 2025 | $13.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.23B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $42.2B |
| FY2017, ended Dec 31, 2017 | $46.8B |
| FY2018, ended Dec 31, 2018 | $52.9B |
| FY2019, ended Dec 31, 2019 | $70.4B |
| FY2020, ended Dec 31, 2020 | $68.3B |
| FY2021, ended Dec 31, 2021 | $58.5B |
| FY2022, ended Dec 31, 2022 | $55.7B |
| FY2023, ended Dec 31, 2023 | $63.0B |
| FY2024, ended Dec 31, 2024 | $60.0B |
| FY2025, ended Dec 31, 2025 | $67.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $70.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 943M |
| FY2017, ended Dec 31, 2017 | 921M |
| FY2018, ended Dec 31, 2018 | 890M |
| FY2019, ended Dec 31, 2019 | 888M |
| FY2020, ended Dec 31, 2020 | 894M |
| FY2021, ended Dec 31, 2021 | 899M |
| FY2022, ended Dec 31, 2022 | 907M |
| FY2023, ended Dec 31, 2023 | 917M |
| FY2024, ended Dec 31, 2024 | 927M |
| FY2025, ended Dec 31, 2025 | 938M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 945M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.50B | $544M |
| FY2017, ended Dec 31, 2017 | $4.34B | $534M |
| FY2018, ended Dec 31, 2018 | $4.44B | $510M |
| FY2019, ended Dec 31, 2019 | $1.36B | $679M |
| FY2020, ended Dec 31, 2020 | — | $937M |
| FY2021, ended Dec 31, 2021 | — | $982M |
| FY2022, ended Dec 31, 2022 | — | $987M |
| FY2023, ended Dec 31, 2023 | — | $1.13B |
| FY2024, ended Dec 31, 2024 | — | $1.31B |
| FY2025, ended Dec 31, 2025 | — | $1.72B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | $1.97B |
Valuation
At current price- Market Cap
- $237B
- P/E
- 21.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.4×
- Price / Book
- 6.7×
- EV / EBITDA
- 16.8×
Growth
Trailing 12 months- Revenue (TTM)
- $69.9B
- Revenue Growth YoY
- 6.8%
- Revenue CAGR 3Y
- 3.7%
- Revenue CAGR 5Y
- 4.1%
- EPS Growth YoY
- 40.2%
- Net Income Growth YoY
- 41.3%
Profitability
Trailing 12 months- Gross Margin
- 58.0%
- Operating Margin
- —
- Net Margin
- 16.0%
- FCF Margin
- 21.0%
- Return on Equity
- 35.2%
Earnings
Trailing 12 months- Net Income
- $11.2B
- EPS (diluted)
- $11.75
- EBITDA
- $17.7B
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $9.23B
- Total Debt
- $70.8B
- Net Debt
- $61.6B
- Total Assets
- $155B
- Total Liabilities
- $119B
- Shareholders' Equity
- $35.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.8B
- Capital Expenditure
- $1.18B
- Free Cash Flow
- $14.7B
Dividends and risk
Last 12 months- Dividend Yield
- 2.7%
- Dividend / Share
- $6.74
- Beta (5Y)
- 0.73
Every ratio is calculated from the company’s reported figures.